The Scientist

» amyloidosis

Most Recent

If approved, patisiran will be the first RNAi therapeutic on the market. 

0 Comments

Popular Now

  1. Sci-Hub Loses Domains and Access to Some Web Services
  2. Nobel Prize–Winning Biologist Dies
  3. CDC: Flu Vaccine 36 Percent Effective So Far
  4. Academics Protest China’s Censorship Requests
AAAS